国新健康
(000503)
| 流通市值：100.95亿 | | | 总市值：101.17亿 |
| 流通股本：9.79亿 | | | 总股本：9.81亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 95,530,059.44 | 50,467,725.8 | 356,896,420.31 | 200,175,797.05 |
| 营业收入 | 95,530,059.44 | 50,467,725.8 | 356,896,420.31 | 200,175,797.05 |
| 二、营业总成本 | 200,420,486.66 | 101,542,262.28 | 497,601,832.31 | 310,493,245.6 |
| 营业成本 | 110,047,478.56 | 57,930,039.64 | 302,447,456.39 | 193,333,505.34 |
| 税金及附加 | 418,063.1 | 58,673.38 | 2,479,857.35 | 1,270,673.72 |
| 销售费用 | 32,429,165.35 | 14,923,130.53 | 72,270,820.15 | 42,708,861.39 |
| 管理费用 | 52,039,538.03 | 26,425,606.59 | 118,099,931.98 | 71,392,383.75 |
| 研发费用 | 1,209,670.2 | 542,165.06 | 339,291.6 | - |
| 财务费用 | 4,276,571.42 | 1,662,647.08 | 1,964,474.84 | 1,787,821.4 |
| 其中:利息费用 | 4,725,108.46 | 2,187,521.63 | 8,310,544 | 5,715,954.47 |
| 其中:利息收入 | 739,230.77 | 605,842.61 | 6,520,652.18 | 4,092,215.61 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 0 | - | 6,340,000 | - |
| 加:投资收益 | 9,609,001.83 | 4,320,158.46 | 143,019,379.11 | 72,827,431.33 |
| 净敞口套期收益 | - | - | 0 | - |
| 资产处置收益 | -5,713.81 | 0 | 33,591.2 | 55,933.8 |
| 资产减值损失(新) | 4,757,551.95 | -1,940,358.04 | -1,961,491.58 | 2,852,277.95 |
| 信用减值损失(新) | -8,231,174.76 | 3,398,061.31 | -23,186,486.13 | -3,190,634.52 |
| 其他收益 | 401,358.81 | 376,689.71 | 690,739.95 | 521,231.53 |
| 四、营业利润 | -98,359,403.2 | -44,919,985.04 | -15,769,679.45 | -37,251,208.46 |
| 加:营业外收入 | 16,738.59 | 6,257.87 | 5,664,099.58 | 5,531,933.08 |
| 减:营业外支出 | 313,744.29 | 38,008.68 | 1,586,974.34 | 344,913.17 |
| 五、利润总额 | -98,656,408.9 | -44,951,735.85 | -11,692,554.21 | -32,064,188.55 |
| 减:所得税费用 | 434,276.5 | 624,803.12 | -226,004.45 | -26,402.34 |
| 六、净利润 | -99,090,685.4 | -45,576,538.97 | -11,466,549.76 | -32,037,786.21 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -99,090,685.4 | -45,576,538.97 | -11,466,549.76 | -32,037,786.21 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -99,090,685.4 | -45,576,538.97 | -10,375,438.31 | -30,946,674.76 |
| 少数股东损益 | - | - | -1,091,111.45 | -1,091,111.45 |
| 扣除非经常损益后的净利润 | -98,811,329.49 | -45,568,538.16 | -151,674,390.39 | -108,733,223.21 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.1 | -0.05 | -0.01 | -0.03 |
| (二)稀释每股收益 | -0.1 | -0.05 | -0.01 | -0.03 |
| 八、其他综合收益 | -53,426.06 | -17,300.36 | -1,315,518.23 | -145,922.56 |
| 归属于母公司股东的其他综合收益 | -53,426.06 | -17,300.36 | -1,315,518.23 | -145,922.56 |
| 九、综合收益总额 | -99,144,111.46 | -45,593,839.33 | -12,782,067.99 | -32,183,708.77 |
| 归属于母公司股东的综合收益总额 | -99,144,111.46 | -45,593,839.33 | -11,690,956.54 | -31,092,597.32 |
| 归属于少数股东的综合收益总额 | - | - | -1,091,111.45 | -1,091,111.45 |
| 公告日期 | 2025-08-28 | 2025-04-25 | 2025-04-25 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |